| Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG |
| Friday, December 09 2005 | |||
Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AGLaval Quebec CANADA, December 9, 2005 – Neptune Technologies and Bioressources (NTB: TSXV), active in the field of high value-added natural product extraction from marine biomass, such as krill, is pleased to announce its strategic alliance with Degussa AG. Degussa AG, the German giant and world’s largest manufacturer of specialty chemicals, is now a premier partner in Neptune’s long-term strategy for R&D; and business development. The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG renowned expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Degussa AG will utilize its knowledge, expertise and high end technologies especially in the field of supercritical extraction know-how, in order for Neptune to accelerate its penetration and to rapidly grow with NKO™ as a functional food ingredient, ingeniously adapted to respond to the new requirements of the dairy and beverage markets, the largest and fastest growing segments of the 66.6B US$ functional food industry. Concurrently Degussa AG and Neptune will join resources to exploit Neptune’s proprietary phospholipids and specifically 3 unique phospholipids known as; PhosphatidylCholine (PC), PhosphatidylEthanolamine (PE) and PhosphatidylInositol (PI), recognized as novel, because they are the only phospholipid carriers of EPA and DHA, omega-3 fatty acids and antioxidants known to science and industry, until today. Among others, this unique feature makes Neptune phospholipids highly stable and effective, characteristics that are considered essential for the use of phospholipids in the nutraceutical, pharmaceutical and nutrigenomic industries. “In line with our mission and business plan, the Degussa AG alliance represents a timely and strategic partnership and it is a significant leap forward for Neptune,” said Mr. Henri Harland, the President and CEO of Neptune Technologies & Bioressources Inc. Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com/ About Degussa AG http://www.degussa.com/ FORWARD-LOOKING STATEMENTS: Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|